CNS Pharmaceuticals, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for CNSP, updated each market day.
CNSP AI Sentiment
AI predicts CNS Pharmaceuticals, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About CNS Pharmaceuticals, Inc. Common Stock
CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.
Sector
Exchange
Market Cap
$1,728,386
Cap Tier
Employees
8
Headquarters
HOUSTON, TX
Listed Since
Nov. 8, 2019
Website
CNSP Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
CNSP Volatility
CNS Pharmaceuticals, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
